revlimid natco

NATCO Pharma Q3 results: Key reasons that cause decline

NATCO Pharma Q3 results: Medical devices manufacturer NATCO Pharma posted its results for the third quarter of fiscal 2024-25 (Q3 2025) on Wednesday reporting a 37.75% year-on-year (YoY) decline causing a drop of 19% in its shares on Thursday.